Ocular Therapeutix To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Jonathan Talamo, M.D., Chief Medical Officer, will present at the Cantor Fitzgerald 2nd Annual Healthcare Conference on Wednesday, July 13, 2016 at 9:30 a.m. ET. The conference will be held at the Le Parker Meridien Hotel in New York, NY.